April 20, 2022 01:04 PM EDTUpdated April 22, 03:45 PM
Pharma
Law

Supreme Court calls on top gov­ern­ment lawyer to weigh PC­SK9 patent ap­peal

Tyler Patchen

News Reporter

An­oth­er chap­ter in the PC­SK9 bat­tle of Am­gen vs. Sanofi and Re­gen­eron is afoot, with the Supreme Court call­ing on the fed­er­al gov­ern­ment’s top lawyer …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times